Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (761-770 of 1,325) with videos related to

Pageof 133
Sort By:
Cancer|April 27, 2012
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809Mark D Hurwitz, Susan Halabi, Laura Archer, et al.
ACS Applied Materials & Interfaces|February 20, 2015
Simple, benign, aqueous-based amination of polycarbonate surfacesVirginia VanDelinder, David R Wheeler, Leo J Small, et al.
Chemical Research in Toxicology|October 1, 1996
Depurinating and stable benzo[a]pyrene-DNA adducts formed in isolated rat liver nucleiP D Devanesan, S Higginbotham, F Ariese, et al.
Endocrinology|May 10, 2000
Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male ratsL J Seal, C J Small, M S Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480D J George, S Halabi, T F Shepard, et al.
Chemical Research in Toxicology|June 21, 2005
Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]PErcole L Cavalieri, Eleanor G Rogan, Kai-Ming Li, et al.
Brain Research|May 3, 2005
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intakeCaroline R Abbott, Caroline J Small, Adam R Kennedy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2021
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registryD H Kwon, R Vashisht, H T Borno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Pain predicts overall survival in men with metastatic castration-refractory prostate cancerSusan Halabi, Nicholas J Vogelzang, Alice B Kornblith, et al.
American Journal of Obstetrics and Gynecology|July 30, 2013
Predictors of failed trial of labor among women with an extremely obese body mass indexRavindu P Gunatilake, Michael P Smrtka, Benjamin Harris, et al.
Pageof 133

Showing results (761-770 of 1,325) with videos related to

Sort By:
Pageof 133
Cancer|April 27, 2012
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809Mark D Hurwitz, Susan Halabi, Laura Archer, et al.
ACS Applied Materials & Interfaces|February 20, 2015
Simple, benign, aqueous-based amination of polycarbonate surfacesVirginia VanDelinder, David R Wheeler, Leo J Small, et al.
Chemical Research in Toxicology|October 1, 1996
Depurinating and stable benzo[a]pyrene-DNA adducts formed in isolated rat liver nucleiP D Devanesan, S Higginbotham, F Ariese, et al.
Endocrinology|May 10, 2000
Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male ratsL J Seal, C J Small, M S Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480D J George, S Halabi, T F Shepard, et al.
Chemical Research in Toxicology|June 21, 2005
Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]PErcole L Cavalieri, Eleanor G Rogan, Kai-Ming Li, et al.
Brain Research|May 3, 2005
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intakeCaroline R Abbott, Caroline J Small, Adam R Kennedy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2021
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registryD H Kwon, R Vashisht, H T Borno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Pain predicts overall survival in men with metastatic castration-refractory prostate cancerSusan Halabi, Nicholas J Vogelzang, Alice B Kornblith, et al.
American Journal of Obstetrics and Gynecology|July 30, 2013
Predictors of failed trial of labor among women with an extremely obese body mass indexRavindu P Gunatilake, Michael P Smrtka, Benjamin Harris, et al.
Pageof 133